CTOs on the Move

Sientra

www.sientra.com

 
Headquartered in Santa Barbara, California, Sientra offers leading transformative treatments and technologies focused on progressing the art of plastic surgery and making a difference in patients` lives. With unrivaled safety, state-of-the-art science and exceptional service; paired with unparalleled partnerships with plastic surgeons, the Sientra portfolio of proprietary innovations radically advances how plastic surgeons think, work and care for their patients. The company`s core breast products segment includes its state-of-the-art Sientra breast implants and its ground-breaking dual-port breast tissue expander, AlloX2® . In addition, the Sientra portfolio also includes BIOCORNEUM® the #1 performing, preferred and recommended scar gel of plastic surgeons(*) ...
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.sientra.com
  • 420 South Fairview Avenue Suite 200
    Santa Barbara, CA USA 93117
  • Phone: 805.562.3500

Executives

Name Title Contact Details

Funding

Sientra raised $115M on 06/11/2019
Sientra raised $36.5M on 02/09/2021

Similar Companies

Equine Medical Ctr

Equine Medical Ctr is a Hoschton, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DKBmed

DKBmed is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Epimed International

Epimed International is a Johnstown, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

TouchPointCare

TouchPointCare is a Libertyville, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Urologix

Urologix, Inc., based in Minneapolis, develops, manufactures, markets and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH). Urologix`s Cooled ThermoTherapy™ produces targeted microwave energy combined with a unique cooling mechanism to protect healthy tissue and enhance patient comfort. The Prostiva® RF Therapy System delivers radio frequency energy directly into the prostate, destroying prostate tissue, reducing constriction of the urethra, and thereby relieving BPH symptoms. Both therapies provide safe, effective and lasting relief of the symptoms and obstruction due to BPH. Prostiva is a registered trademark of Medtronic, Inc., used under license. All other trademarks are the property of Urologix.